Kirkland & Ellis advised middle market private equity firm, Blue Wolf Capital Partners LLC in the acquisition of seven manufacturing and development facilities: Solna, Stängnäs, Höganäs, Karlskoga and Uppsala OTC Development in Sweden, Pessac in France, and Parets in Spain, from Recipharm, a contract development and manufacturing organization (“CDMO”) headquartered in Stockholm. The transaction was announced April 2, 2024. Read Blue Wolf’s press release The Kirkland team was led by corporate partners Laura Sullivan, Jacob Traff and Nick Appleton and associate Jack Evans and technology & IP transaction partner Jacqueline Clover and associates Stephen Coudounaris and Noémie Broussoux-Coutard.